Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 63-70

  Cohn, Jeffrey S ^a   Tremblay, Michel ^a   Boulet, Lucie ^a   Jacques, Hélène ^a   Davignon, Jean ^a   Roy, Madeleine ^a   Bernier, Lise ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Atherosclerosis; Cholesterol; Lipoprotein metabolism; Triglyceride

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ALLELE; ARTICLE; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL HYPERLIPEMIA; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROCESSING; ULTRACENTRIFUGATION;

EID: 0037968932     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00139-4     Document Type: Article

References (40)

1. Sehayek E., Eisenberg S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266:1991;18259-18267.
2. Clavey V.S., Lestavel-Delattre S., Copin C., Bard J.M., Fruchart J.C. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb. Vasc. Biol. 15:1995;963-971.
3. Kowal R.C., Herz J., Weisgraber K.H., Mahley R.W., Brown M.S., Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;10771-10779.
4. Weisgraber K.H., Mahley R.W., Kowal R.C., Herz J., Goldstein J.L., Brown M.S. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;22453-22459.
5. Jong M.C., van Dijk K.W., Dahlmans V.E., van der Boom H., Kobayashi K., Oka K., Siest G., Chan L., Hofker M.H., Havekes L.M. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem. J. 338:1999;281-287.
6. Gautier T., Masson D., de Barros J.-P.P., Athias A., Gambert P., Aunis D., Metz-Boutigue M.-H., Lagrost L. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J. Biol. Chem. 275:2000;37504-37509.
7. Buchko G.W., Rozek A., Kanda P., Kennedy M.A., Cushley R.J. Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase. Protein Sci. 9:2000;1548-1558.
8. Jong M.C., Voshol P.J., Muurling M., Dahlmans V.E., Romijn J.A., Pijl H., Havekes L.M. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes. 50:2001;2779-2785.
9. Simonet W.S., Bucay N., Pitas R.E., Lauer S.J., Taylor J.M. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266:1991;8651-8654.
10. Shachter N.S., Ebara T., Ramakrishnan R., Steiner G., Breslow J.L., Ginsberg H.N., Smith J.D. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI. J. Clin. Invest. 98:1996;846-855.
11. Jong M.C., Gijbels M.J.J., Dahlmans V.E.H., van Gorp P.J.J., Koopman S.-J., Ponec M., Hofker M.H., Havekes L.M. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J. Clin. Invest. 101:1998;145-152.
12. Holmquist L. Quantitation of human serum very low density apolipoproteins C-I, C-II, C-III and E by enzyme immunoassay. J. Immunol. Methods. 34:1980;243-251.
13. Curry M.D., McConathy W.J., Fesmire J.D., Alaupovic P. Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin. Chem. 27:1981;543-548.
14. Carlson L.A., Holmquist L. Concentrations of apolipoproteins B, C-I, C-II, C-III and E in sera from normal men and their relation to serum lipoprotein levels. Clin. Chim. Acta. 124:1982;163-178.
15. Riesen W.F., Sturzenegger E. Enzyme-linked immunosorbent assay for apolipoprotein C-I. J. Clin. Chem. Clin. Biochem. 24:1986;723-727.
16. Wahlberg G., Holmquist L., Walldius G., Annuzzi G. Effects of nicotinic acid on concentrations of serum apolipoproteins B, C-I, C-II, C-III and E in hyperlipidemic patients. Acta Med. Scand. 224:1988;319-327.
17. Bren N.D., Rastogi A., Kottke B. Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays. Mayo Clin. Proc. 68:1993;657-664.
18. Alaupovic P., Schaefer E.J., McConathy W.J., Fesmire J.D., Brewer H.B. Jr. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease). Metabolism. 30:1981;805-809.
19. Annuzzi G., Holmquist L., Carlson L.A. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia. Scand. J. Clin. Lab. Invest. 49:1989;73-81.
20. Björkegren J., Karpe F., Milne R.W., Hamsten A. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. J. Lipid Res. 39:1998;1412-1420.
21. Smit M., van de Kooil-Meijs E., Woudt L.P., Havekes L.M., Frants R.R. Exact localization of the familial dysbetalipoproteinemia associated restriction site in the promoter region of the apoC1 gene. Biochem. Biophys. Res. Commun. 152:1988;1282-1288.
22. Xu Y., Berglund L., Ramakrishnan R., Mayeux R., Ngai C., Holleran S., Tycko B., Leff T., Shachter N.S. A common HPA I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res. 40:1999;50-58.
23. Plasma lipid distribution in selected North American populations: the Lipid Research Clinics Program prevalence study. Circulation. 60:1979;427-439.
24. Warnick G.R., Albers J.J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J. Lipid Res. 19:1978;65-76.
25. Hill J.S., Pritchard P.H. Improved phenotyping of apolipoprotein E: application to population frequency distribution. Clin. Chem. 36:1990;1871-1874.
26. Cohn J.S., Tremblay M., Amiot M., Bouthillier D., Roy M., Genest J. Jr, Davignon J. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16:1996;149-159.
27. Fredenrich A., Giroux L.-M., Tremblay M., Krimbou L., Davignon J., Cohn J.S. Plasma lipoprotein distribution of apoC-III in normolipidemic and hyperlipidemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid Res. 38:1997;1421-1432.
28. Cohn J.S., Tremblay M., Batal R., Jacques H., Veilleux L., Rodriguez C., Bernier L., Mamer O., Davignon J. Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects. J. Lipid Res. 43:2002;1680-1687.
29. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoproteinE by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
30. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
31. Schaefer E.J., Lamon-Fava S., Johnson S., Ordovas J.M., Schaefer M.M., Castelli W.P., Wilson P.W.F. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler. Thromb. 14:1994;1105-1113.
32. Smit M., de Knif P., Rosseneu M., Bury J., Klasen E., Frants R., Havekes L. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum. Genet. 80:1988;287-292.
33. Luc G., Ducimetiere P., Bard J.-M., Arvelier D., Evans A., Cambien F., Fruchart J.-C., Fievet C. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype. Atherosclerosis. 131:1997;257-262.
34. Schiele F., Vincent-Viry M., Starck M., Beaud B., Hennache G., Siest G., Visvikis S., Herbeth B. Apolipoprotein E in apolipoprotein B (apo B)- and non-apo B-containing lipoproteins in 3523 participants in the Stanislas Cohort: biological variation and genotype-specific reference limits. Clin. Chem. 48:2002;291-300.
35. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages; a critical role for the nuclear receptors LXRalpha and LXRbeta, J Biol Chem 2002;277:31900-8.
36. Allan C.M., Walker D., Taylor J.M. Evolutionary duplication of a hepatic control region in the human apolipoprotein E gene locus. Identification of a second region that confers high level and liver-specific expression of the human apolipoprotein E gene in transgenic mice. J. Biol. Chem. 270:1995;26278-26281.
37. Allan C.M., Walker D., Segrest J.P., Taylor J.M. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics. 28:1995;291-300.
38. Shih S.J., Allan C., Grehan S., Tse E., Moran C., Taylor J.M. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem. 275:2000;31567-31572.
39. Mahley R.W., Rall S.C. Jr. Type III hyperlipoproteinemia (dysbeta-lipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. 1989;1195-1213 McGraw-Hill Publishing Co, New York, NY.
40. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 33:1992;447-454.